Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1114 | 1150 | 1017 | 1444 | 2286 |
Fund Return | 4.22% | 11.44% | 15.03% | 0.55% | 7.62% | 8.62% |
Place in category | 499 | 380 | 201 | 330 | 181 | 59 |
% in Category | 48 | 34 | 22 | 56 | 43 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiD | 2.12B | 4.11 | -0.10 | 7.92 | ||
Wellington Global Health Care EquUG | 2.12B | 0.58 | -0.92 | 9.63 | ||
Wellington Global Health Care EquiN | 2.12B | 0.54 | -1.41 | 9.08 | ||
Wellington Enduring Assets Fund USD | 522.29M | -2.39 | 1.90 | 5.89 | ||
Wellington Emerging Markets EquityT | 34.46M | 1.50 | -7.36 | 4.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund A U | 3.98B | 6.41 | 4.36 | 8.61 | ||
Janus Global Life Sciences Fund I U | 3.98B | 6.56 | 5.22 | 9.45 | ||
Wellington Global Health Care EquiD | 2.12B | 4.11 | -0.10 | 7.92 | ||
Wellington Global Health Care EquUG | 2.12B | 0.58 | -0.92 | 9.63 | ||
Wellington Global Health Care EquiN | 2.12B | 0.54 | -1.41 | 9.08 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.93 | 741.89 | -1.53% | |
UnitedHealth | US91324P1021 | 6.91 | 600.25 | -0.04% | |
Merck&Co | US58933Y1055 | 5.37 | 97.29 | -0.15% | |
AstraZeneca | GB0009895292 | 4.36 | 10,014.0 | +0.45% | |
Novartis | CH0012005267 | 3.53 | 91.29 | +0.33% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review